Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12163086rdf:typepubmed:Citationlld:pubmed
pubmed-article:12163086lifeskim:mentionsumls-concept:C0018823lld:lifeskim
pubmed-article:12163086lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:12163086lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:12163086pubmed:issue8lld:pubmed
pubmed-article:12163086pubmed:dateCreated2002-8-6lld:pubmed
pubmed-article:12163086pubmed:abstractTextDonor availability is currently the major factor limiting the use of heart transplantation as a treatment for severe heart failure. Heterotopic heart transplantation may address this issue by allowing the use of smaller donor organs, which otherwise may not be used.lld:pubmed
pubmed-article:12163086pubmed:languageenglld:pubmed
pubmed-article:12163086pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12163086pubmed:citationSubsetIMlld:pubmed
pubmed-article:12163086pubmed:statusMEDLINElld:pubmed
pubmed-article:12163086pubmed:monthAuglld:pubmed
pubmed-article:12163086pubmed:issn1053-2498lld:pubmed
pubmed-article:12163086pubmed:authorpubmed-author:YacoubM HMHlld:pubmed
pubmed-article:12163086pubmed:authorpubmed-author:MitchellA GAGlld:pubmed
pubmed-article:12163086pubmed:authorpubmed-author:KhaghaniAAlld:pubmed
pubmed-article:12163086pubmed:authorpubmed-author:BannerN RNRlld:pubmed
pubmed-article:12163086pubmed:authorpubmed-author:AnyanwuA CAClld:pubmed
pubmed-article:12163086pubmed:authorpubmed-author:BleasdaleR...lld:pubmed
pubmed-article:12163086pubmed:issnTypePrintlld:pubmed
pubmed-article:12163086pubmed:volume21lld:pubmed
pubmed-article:12163086pubmed:ownerNLMlld:pubmed
pubmed-article:12163086pubmed:authorsCompleteYlld:pubmed
pubmed-article:12163086pubmed:pagination867-73lld:pubmed
pubmed-article:12163086pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:meshHeadingpubmed-meshheading:12163086...lld:pubmed
pubmed-article:12163086pubmed:year2002lld:pubmed
pubmed-article:12163086pubmed:articleTitleDeterminants of outcome after heterotopic heart transplantation.lld:pubmed
pubmed-article:12163086pubmed:affiliationDepartment of Transplant Cardiology, Royal Brompton and Harefield NHS Trust, Harefield Hospital, Middlesex, United Kingdom.lld:pubmed
pubmed-article:12163086pubmed:publicationTypeJournal Articlelld:pubmed